Lineage Cell Therapeutics (LCTX) Enterprise Value (2010 - 2026)
Lineage Cell Therapeutics (LCTX) reported Enterprise Value of $279.36 million for Q2 2026, up 70.1% from $164.24 million a year earlier but down 17.7% from the prior quarter.
Lineage Cell Therapeutics (LCTX) Enterprise Value (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Lineage Cell Therapeutics' Enterprise Value came in at $129.71 million, up 262.1% year-over-year; for FY2025, it was $349.03 million, up 471.9% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
- By year, Enterprise Value came in at $61.03 million in FY2024 (-60.3%), $153.85 million in FY2023 (+10.1%), $139.73 million in FY2022 (-60.7%) and $355.54 million in FY2021 (+60.9%).
- Five-year quarterly Enterprise Value spans a low of $53.48 million in Q1 2025 and a high of $358.3 million in Q3 2021.
- Year over year, Enterprise Value has now increased in each of the last five quarters, with growth averaging 135.7% over the last eight quarters.
- The high point for year-over-year Enterprise Value in five years was Q1 2026 (growth of 534.5%); the low point was Q1 2025 (a decline of 77.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $339.33 million (Q1 2026), $349.03 million (Q4 2025) and $347.52 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 279.36 Mn |
| Mar 31, 2026 | 339.33 Mn |
| Dec 31, 2025 | 349.03 Mn |
| Sep 30, 2025 | 347.52 Mn |
| Jun 30, 2025 | 164.24 Mn |
| Mar 31, 2025 | 53.48 Mn |
| Dec 31, 2024 | 61.03 Mn |
| Sep 30, 2024 | 137.74 Mn |
| Jun 30, 2024 | 148.90 Mn |
| Mar 31, 2024 | 234.32 Mn |
| Dec 31, 2023 | 153.85 Mn |
| Sep 30, 2023 | 163.65 Mn |
| Jun 30, 2023 | 198.63 Mn |
| Mar 31, 2023 | 207.01 Mn |
| Dec 31, 2022 | 139.73 Mn |
| Sep 30, 2022 | 124.22 Mn |
| Jun 30, 2022 | 194.82 Mn |
| Mar 31, 2022 | 180.11 Mn |
| Dec 31, 2021 | 355.54 Mn |
| Sep 30, 2021 | 358.30 Mn |
Lineage Cell Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=LCTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();